# Lapam Capital

Lapam Capital is a Private Equity based in Beijing, China.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Beijing, China
- **Region:** Asia
- **Address:** Beijing, China
- **Founded:** 2010
- **Assets under management:** Undisclosed
- **Website:** www.lapamcapital.com
- **LinkedIn:** linkedin.com/company/lapam

## Regulatory record

- **Reports private funds:** No

## About

Lapam Capital is a healthcare-focused venture capital firm. It targets early-stage and fast-growing opportunities. Lapam Capital has made 101 investments, including a Seed VC investment in Maibo Zhixing on March 23, 2026. The firm has 12 portfolio exits, with Leads Biolabs exiting on July 25, 2025.

## Sectors

- Enterprise Software
- AI/ML
- Digital Health
- Industrial Tech

## Questions

### What investment stages does Lapam Capital target?

Lapam Capital deploys across early-stage seed, start-up, and growth equity rounds. The firm can enter at university spinout stage and follow on through Series A and later rounds, concentrating capital in mainland China's hard-technology and enterprise sectors.

### How does Lapam Capital source deals?

The firm's sourcing model draws on relationships with university technology transfer offices, state-backed guidance funds, and China's three primary venture hubs — Beijing, Shenzhen, and Shanghai. Deal flow is closely tied to government technology roadmaps and the policy cycles that determine when procurement budgets or subsidies become available for sectors like semiconductors and AI infrastructure.

### Which sectors does Lapam explicitly avoid?

Lapam Capital does not publish exclusion lists. Its portfolio composition and policy-aligned mandate suggest the firm avoids consumer-facing internet platforms and business models that fall outside state-designated strategic technology priorities. No real estate, entertainment, or traditional consumer-goods investments appear in its disclosed posture.

### How is Lapam Capital funded?

The firm's limited partner base is not publicly disclosed. Chinese private equity firms of Lapam's profile commonly raise capital from domestic institutional investors, government guidance funds, state-owned enterprise subsidiaries, and high-net-worth individuals. No foreign LP relationships are publicly documented.

### Does Lapam Capital co-invest alongside external GPs?

Lapam's structure supports co-investment activity, most frequently alongside Chinese state-backed funds and corporate venture arms aligned with the same industrial-policy priorities. The firm does not market co-investment programs to international GPs, and its capital is deployed exclusively within mainland China.

## Related profiles

- [Lanzhou Kefa Fund Management](https://altss.com/profile/lanzhou-kefa-fund-management)
- [Larix VC](https://altss.com/profile/larix-vc)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/lapam-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology